Ligand profile
ZINC2984023
Virtual-screening candidate from ZINC.
Bound to: VK055_1359 — NADH dehydrogenase II
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2984023- UniProt (similar protein)
Q8I302- Tanimoto
- 0.583
- Target protein
- VK055_1359
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 36.9
- −1 ≤ LogP ≤ 5 4.47
- MW ≤ 500 Da 344.5
- LogP ≤ 5 4.47
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 36.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1ccc(OCCOCCOc2ccc(C(C)(C)C)cc2)cc1COc1ccc(OCCOCCOc2ccc(C(C)(C)C)cc2)cc1
InChI=1S/C21H28O4/c1-21(2,3)17-5-7-19(8-6-17)24-15-13-23-14-16-25-20-11-9-18(22-4)10-12-20/h5-12H,13-16H2,1-4H3InChI=1S/C21H28O4/c1-21(2,3)17-5-7-19(8-6-17)24-15-13-23-14-16-25-20-11-9-18(22-4)10-12-20/h5-12H,13-16H2,1-4H3
MOYKQSLQEPQMSN-UHFFFAOYSA-NMOYKQSLQEPQMSN-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- TRT
- Homolog
- Q8I302
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2984023 →
- ZINC ZINC20 ZINC2984023 →
- UniProt UniProt Q8I302 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2984023”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1359.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).